IP Issues Associated with Clinical Trials in Biopharma
- Eric K. Steffe
- Sterne, Kessler, Goldstein & Fox
In this video, Eric Steffe discusses how biotechnology companies are often unprepared for the intellectual property issues that arise as a promising drug progresses through clinical trials and explains the benefits of obtaining patent protection for discoveries that occur during the clinical trial process.
To view the video, click here.